Dr Severn G Barloco, MD | |
14300 Orchard Pkwy, Suite 430, Westminster, CO 80023-9206 | |
(303) 430-3900 | |
(303) 430-3910 |
Full Name | Dr Severn G Barloco |
---|---|
Gender | Male |
Speciality | General Surgery |
Experience | 23 Years |
Location | 14300 Orchard Pkwy, Westminster, Colorado |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1164515847 | NPI | - | NPPES |
03852521 | Medicaid | CO | |
8F7604 | Other | CO | MEDICARE PTAN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | DR49184 (Colorado) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Centura Health-st Anthony North Health Campus | Westminster, CO | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Valley View Hospital Association | 1850294778 | 167 |
Acute Care Surgery Medical Group Inc | 7214006816 | 146 |
News Archive
Women with pelvic floor disorders suffer from urinary and fecal incontinence as well as prolapse of the bowel, bladder and reproductive organs. (Bowel prolapse occurs when the bowel slips out of place, and pushes up against the walls of the vagina, which may cause a great deal of discomfort.)
Advanced melanoma, the most deadly form of skin cancer, can be successfully treated in some cases by vaccinating patients with tumor proteins.
Sorrento Therapeutics, Inc. and B.G. Negev Technologies and Applications Ltd., the technology transfer company of Ben-Gurion University of the Negev, have announced an option and license agreement to develop therapeutic products to treat Hepatitis C Virus.
Profectus BioSciences, Inc., a clinical-stage vaccine company developing novel vaccines for the prevention and treatment of infectious diseases and the treatment of cancer, announced today the initiation of a Phase 1 clinical study of Profectus' VesiculoVax-vectored Ebola virus vaccine.
› Verified 7 days ago
Entity Name | Catholic Health Initiatives Colorado |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1356783351 PECOS PAC ID: 8022927342 Enrollment ID: O20031215000462 |
News Archive
Women with pelvic floor disorders suffer from urinary and fecal incontinence as well as prolapse of the bowel, bladder and reproductive organs. (Bowel prolapse occurs when the bowel slips out of place, and pushes up against the walls of the vagina, which may cause a great deal of discomfort.)
Advanced melanoma, the most deadly form of skin cancer, can be successfully treated in some cases by vaccinating patients with tumor proteins.
Sorrento Therapeutics, Inc. and B.G. Negev Technologies and Applications Ltd., the technology transfer company of Ben-Gurion University of the Negev, have announced an option and license agreement to develop therapeutic products to treat Hepatitis C Virus.
Profectus BioSciences, Inc., a clinical-stage vaccine company developing novel vaccines for the prevention and treatment of infectious diseases and the treatment of cancer, announced today the initiation of a Phase 1 clinical study of Profectus' VesiculoVax-vectored Ebola virus vaccine.
› Verified 7 days ago
Entity Name | Sangre De Cristo Surgical Associates Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1184645418 PECOS PAC ID: 8224927801 Enrollment ID: O20040311001470 |
News Archive
Women with pelvic floor disorders suffer from urinary and fecal incontinence as well as prolapse of the bowel, bladder and reproductive organs. (Bowel prolapse occurs when the bowel slips out of place, and pushes up against the walls of the vagina, which may cause a great deal of discomfort.)
Advanced melanoma, the most deadly form of skin cancer, can be successfully treated in some cases by vaccinating patients with tumor proteins.
Sorrento Therapeutics, Inc. and B.G. Negev Technologies and Applications Ltd., the technology transfer company of Ben-Gurion University of the Negev, have announced an option and license agreement to develop therapeutic products to treat Hepatitis C Virus.
Profectus BioSciences, Inc., a clinical-stage vaccine company developing novel vaccines for the prevention and treatment of infectious diseases and the treatment of cancer, announced today the initiation of a Phase 1 clinical study of Profectus' VesiculoVax-vectored Ebola virus vaccine.
› Verified 7 days ago
Entity Name | Valley View Hospital Association |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1518353218 PECOS PAC ID: 1850294778 Enrollment ID: O20150731016418 |
News Archive
Women with pelvic floor disorders suffer from urinary and fecal incontinence as well as prolapse of the bowel, bladder and reproductive organs. (Bowel prolapse occurs when the bowel slips out of place, and pushes up against the walls of the vagina, which may cause a great deal of discomfort.)
Advanced melanoma, the most deadly form of skin cancer, can be successfully treated in some cases by vaccinating patients with tumor proteins.
Sorrento Therapeutics, Inc. and B.G. Negev Technologies and Applications Ltd., the technology transfer company of Ben-Gurion University of the Negev, have announced an option and license agreement to develop therapeutic products to treat Hepatitis C Virus.
Profectus BioSciences, Inc., a clinical-stage vaccine company developing novel vaccines for the prevention and treatment of infectious diseases and the treatment of cancer, announced today the initiation of a Phase 1 clinical study of Profectus' VesiculoVax-vectored Ebola virus vaccine.
› Verified 7 days ago
Entity Name | Acute Care Surgery Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1700069549 PECOS PAC ID: 7214006816 Enrollment ID: O20221206002128 |
News Archive
Women with pelvic floor disorders suffer from urinary and fecal incontinence as well as prolapse of the bowel, bladder and reproductive organs. (Bowel prolapse occurs when the bowel slips out of place, and pushes up against the walls of the vagina, which may cause a great deal of discomfort.)
Advanced melanoma, the most deadly form of skin cancer, can be successfully treated in some cases by vaccinating patients with tumor proteins.
Sorrento Therapeutics, Inc. and B.G. Negev Technologies and Applications Ltd., the technology transfer company of Ben-Gurion University of the Negev, have announced an option and license agreement to develop therapeutic products to treat Hepatitis C Virus.
Profectus BioSciences, Inc., a clinical-stage vaccine company developing novel vaccines for the prevention and treatment of infectious diseases and the treatment of cancer, announced today the initiation of a Phase 1 clinical study of Profectus' VesiculoVax-vectored Ebola virus vaccine.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Severn G Barloco, MD 14300 Orchard Pkwy, Suite 430, Westminster, CO 80023-9206 Ph: (303) 430-3900 | Dr Severn G Barloco, MD 14300 Orchard Pkwy, Suite 430, Westminster, CO 80023-9206 Ph: (303) 430-3900 |
News Archive
Women with pelvic floor disorders suffer from urinary and fecal incontinence as well as prolapse of the bowel, bladder and reproductive organs. (Bowel prolapse occurs when the bowel slips out of place, and pushes up against the walls of the vagina, which may cause a great deal of discomfort.)
Advanced melanoma, the most deadly form of skin cancer, can be successfully treated in some cases by vaccinating patients with tumor proteins.
Sorrento Therapeutics, Inc. and B.G. Negev Technologies and Applications Ltd., the technology transfer company of Ben-Gurion University of the Negev, have announced an option and license agreement to develop therapeutic products to treat Hepatitis C Virus.
Profectus BioSciences, Inc., a clinical-stage vaccine company developing novel vaccines for the prevention and treatment of infectious diseases and the treatment of cancer, announced today the initiation of a Phase 1 clinical study of Profectus' VesiculoVax-vectored Ebola virus vaccine.
› Verified 7 days ago
Dr. Michael B Clendenin, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 500 W 144th Ave Ste 230, Westminster, CO 80023 Phone: 303-665-2603 Fax: 303-665-2605 | |
Phiet The Bui, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 500 W 144th Ave Ste 130, Westminster, CO 80023 Phone: 720-927-2700 Fax: 720-927-2701 | |
Katrina Schmidt Oyague, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 14300 Orchard Pkwy, Westminster, CO 80023 Phone: 303-470-3900 Fax: 303-430-3910 | |
Andrea Elaine Boedecker, D.O. Surgery Medicare: Medicare Enrolled Practice Location: 11230 Benton St, Westminster, CO 80020 Phone: 720-282-8010 |